{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T09:32:03Z","timestamp":1787909523162,"version":"build-2784847793"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T00:00:00Z","timestamp":1533772800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s11095-018-2464-8","type":"journal-article","created":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T15:40:23Z","timestamp":1533829223000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Co-Delivery of Ciprofloxacin and Colistin in Liposomal Formulations with Enhanced In Vitro Antimicrobial Activities against Multidrug Resistant Pseudomonas aeruginosa"],"prefix":"10.1007","volume":"35","author":[{"given":"Shaoning","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peizhi","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guihong","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi H.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasini","family":"Wickremasinghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nivedita","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhong","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1438-6990","authenticated-orcid":false,"given":"Qi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,9]]},"reference":[{"issue":"6","key":"2464_CR1","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.ijmm.2017.07.004","volume":"307","author":"S Stefani","year":"2017","unstructured":"Stefani S, Campana S, Cariani L, Carnovale V, Colombo C, Lleo MM, et al. Relevance of multidrug-resistant Pseudomonas aeruginosa infections in cystic fibrosis. Int J Med Microbiol: IJMM. 2017;307(6):353\u201362.","journal-title":"Int J Med Microbiol: IJMM"},{"issue":"1","key":"2464_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.diagmicrobio.2017.06.009","volume":"89","author":"TD Trinh","year":"2017","unstructured":"Trinh TD, Zasowski EJ, Claeys KC, Lagnf AM, Kidambi S, Davis SL, et al. Multidrug-resistant Pseudomonas aeruginosa lower respiratory tract infections in the intensive care unit: prevalence and risk factors. Diagn Microbiol Infect Dis. 2017;89(1):61\u20136.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"9","key":"2464_CR3","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S1473-3099(06)70580-1","volume":"6","author":"J Li","year":"2006","unstructured":"Li J, Nation RL, Turnidge JD, Milne RW, Coulthard K, Rayner CR, et al. Colistin: the re-emerging antibiotic for multidrug-resistant gram-negative bacterial infections. Lancet Infect Dis. 2006;6(9):589\u2013601.","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"2464_CR4","doi-asserted-by":"publisher","first-page":"3783","DOI":"10.1128\/AAC.00903-09","volume":"54","author":"PJ Bergen","year":"2010","unstructured":"Bergen PJ, Bulitta JB, Forrest A, Tsuji BT, Li J, Nation RL. Pharmacokinetic\/pharmacodynamic investigation of colistin against Pseudomonas aeruginosa using an in vitro model. Antimicrob Agents Chemother. 2010;54(9):3783\u20139.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"2464_CR5","first-page":"391","volume":"7","author":"HK Johansen","year":"2008","unstructured":"Johansen HK, Moskowitz SM, Ciofu O, Pressler T, Hoiby N. Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients. Journal of cystic fibrosis: official journal of the European cystic fibrosis. Society. 2008;7(5):391\u20137.","journal-title":"Society"},{"issue":"9","key":"2464_CR6","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1128\/AAC.00103-06","volume":"50","author":"J Li","year":"2006","unstructured":"Li J, Rayner CR, Nation RL, Owen RJ, Spelman D, Tan KE, et al. Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2006;50(9):2946\u201350.","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"2464_CR7","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1128\/AAC.01571-06","volume":"51","author":"CH Tan","year":"2007","unstructured":"Tan CH, Li J, Nation RL. Activity of colistin against heteroresistant Acinetobacter baumannii and emergence of resistance in an in vitro pharmacokinetic\/pharmacodynamic model. Antimicrob Agents Chemother. 2007;51(9):3413\u20135.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"2464_CR8","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1093\/jac\/dkn425","volume":"62","author":"A Poudyal","year":"2008","unstructured":"Poudyal A, Howden BP, Bell JM, Gao W, Owen RJ, Turnidge JD, et al. In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae. J Antimicrob Chemother. 2008;62(6):1311\u20138.","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"2464_CR9","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1093\/jac\/dkq226","volume":"65","author":"RV Dudhani","year":"2010","unstructured":"Dudhani RV, Turnidge JD, Nation RL, Li J. fAUC\/MIC is the most predictive PK\/PD index of colistin against Acinetobacter baumannii in murine thigh and lung infection models. J Antimicrob Chemother. 2010;65(9):1984\u201390.","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"2464_CR10","doi-asserted-by":"publisher","first-page":"4503","DOI":"10.1128\/AAC.01707-09","volume":"54","author":"CA Deryke","year":"2010","unstructured":"Deryke CA, Crawford AJ, Uddin N, Wallace MR. Colistin dosing and nephrotoxicity in a large community teaching hospital. Antimicrob Agents Chemother. 2010;54(10):4503\u20135.","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"2464_CR11","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00228-015-1865-4","volume":"71","author":"A Ordooei Javan","year":"2015","unstructured":"Ordooei Javan A, Shokouhi S, Sahraei Z. A review on colistin nephrotoxicity. Eur J Clin Pharmacol. 2015;71(7):801\u201310.","journal-title":"Eur J Clin Pharmacol"},{"issue":"9","key":"2464_CR12","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/j.1469-0691.2008.02061.x","volume":"14","author":"N Petrosillo","year":"2008","unstructured":"Petrosillo N, Ioannidou E, Falagas ME. Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies. Clin Microbiol Infect. 2008;14(9):816\u201327.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"2464_CR13","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1179\/joc.2003.15.3.235","volume":"15","author":"EJ Giamarellos-Bourboulis","year":"2003","unstructured":"Giamarellos-Bourboulis EJ, Sambatakou H, Galani I, Giamarellou H. In vitro interaction of colistin and rifampin on multidrug-resistant Pseudomonas aeruginosa. J Chemother. 2003;15(3):235\u20138.","journal-title":"J Chemother"},{"issue":"7","key":"2464_CR14","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.ebiom.2015.05.021","volume":"2","author":"L Lin","year":"2015","unstructured":"Lin L, Nonejuie P, Munguia J, Hollands A, Olson J, Dam Q, et al. Azithromycin synergizes with cationic antimicrobial peptides to exert bactericidal and therapeutic activity against highly multidrug-resistant gram-negative bacterial pathogens. EBioMedicine. 2015;2(7):690\u20138.","journal-title":"EBioMedicine"},{"issue":"7","key":"2464_CR15","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1080\/23744235.2017.1296183","volume":"49","author":"T Tangden","year":"2017","unstructured":"Tangden T, Karvanen M, Friberg LE, Odenholt I, Cars O. Assessment of early combination effects of colistin and meropenem against Pseudomonas aeruginosa and Acinetobacter baumannii in dynamic time-kill experiments. Infect Dis. 2017;49(7):521\u20137.","journal-title":"Infect Dis"},{"issue":"5","key":"2464_CR16","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1093\/jac\/dku567","volume":"70","author":"NS Ly","year":"2015","unstructured":"Ly NS, Bulitta JB, Rao GG, Landersdorfer CB, Holden PN, Forrest A, et al. Colistin and doripenem combinations against Pseudomonas aeruginosa: profiling the time course of synergistic killing and prevention of resistance. J Antimicrob Chemother. 2015;70(5):1434\u201342.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"2464_CR17","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1128\/AAC.04011-14","volume":"59","author":"JM Buyck","year":"2015","unstructured":"Buyck JM, Tulkens PM, Van Bambeke F. Activities of antibiotic combinations against resistant strains of Pseudomonas aeruginosa in a model of infected THP-1 monocytes. Antimicrob Agents Chemother. 2015;59(1):258\u201368.","journal-title":"Antimicrob Agents Chemother"},{"key":"2464_CR18","doi-asserted-by":"crossref","unstructured":"Hoiby N, Frederiksen B, Pressler T. Eradication of early Pseudomonas aeruginosa infection. J Cyst Fibros. 2005;4 Suppl 2:49\u201354.","DOI":"10.1016\/j.jcf.2005.05.018"},{"key":"2464_CR19","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.msec.2016.11.073","volume":"71","author":"S Zununi Vahed","year":"2017","unstructured":"Zununi Vahed S, Salehi R, Davaran S, Sharifi S. Liposome-based drug co-delivery systems in cancer cells. Mater Sci Eng C Mater Biol Appl. 2017;71:1327\u201341.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"1","key":"2464_CR20","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","volume":"65","author":"TM Allen","year":"2013","unstructured":"Allen TM, Cullis PR. Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev. 2013;65(1):36\u201348.","journal-title":"Adv Drug Deliv Rev"},{"key":"2464_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.addr.2014.05.001","volume":"75","author":"D Cipolla","year":"2014","unstructured":"Cipolla D, Shekunov B, Blanchard J, Hickey A. Lipid-based carriers for pulmonary products: preclinical development and case studies in humans. Adv Drug Deliv Rev. 2014;75:53\u201380.","journal-title":"Adv Drug Deliv Rev"},{"key":"2464_CR22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.addr.2014.10.022","volume":"85","author":"QT Zhou","year":"2015","unstructured":"Zhou QT, Leung SSY, Tang P, et al. Inhaled formulations and pulmonary drug delivery systems for respiratory infections. Adv Drug Deliv Rev. 2015;85:83\u201399.","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"2464_CR23","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1517\/17425247.2011.566552","volume":"8","author":"J Gubernator","year":"2011","unstructured":"Gubernator J. Active methods of drug loading into liposomes: recent strategies for stable drug entrapment and increased in vivo activity. Expert Opin Drug Deliv. 2011;8(5):565\u201380.","journal-title":"Expert Opin Drug Deliv"},{"key":"2464_CR24","first-page":"679109","volume":"2015","author":"Z Yu","year":"2015","unstructured":"Yu Z, Qin W, Lin J, Fang S, Qiu J. Antibacterial mechanisms of polymyxin and bacterial resistance. Biomed Res Int. 2015;2015:679109.","journal-title":"Biomed Res Int"},{"issue":"9","key":"2464_CR25","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/S0006-2952(02)01346-1","volume":"64","author":"A Omri","year":"2002","unstructured":"Omri A, Suntres ZE, Shek PN. Enhanced activity of liposomal polymyxin B against Pseudomonas aeruginosa in a rat model of lung infection. Biochem Pharmacol. 2002;64(9):1407\u201313.","journal-title":"Biochem Pharmacol"},{"issue":"1\u20132","key":"2464_CR26","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ijpharm.2016.10.001","volume":"515","author":"Y Li","year":"2016","unstructured":"Li Y, Tang C, Zhang E, Yang L. Colistin-entrapped liposomes driven by the electrostatic interaction: mechanism of drug loading and in vivo characterization. Int J Pharm. 2016;515(1\u20132):20\u20139.","journal-title":"Int J Pharm"},{"issue":"2","key":"2464_CR27","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jconrel.2012.01.004","volume":"160","author":"M Bachar","year":"2012","unstructured":"Bachar M, Mandelbaum A, Portnaya I, Perlstein H, Even-Chen S, Barenholz Y, et al. Development and characterization of a novel drug nanocarrier for oral delivery, based on self-assembled beta-casein micelles. J Control Release: Official Journal of the Controlled Release Society. 2012;160(2):164\u201371.","journal-title":"J Control Release: Official Journal of the Controlled Release Society"},{"issue":"1","key":"2464_CR28","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/jps.23795","volume":"103","author":"D Cipolla","year":"2014","unstructured":"Cipolla D, Wu H, Eastman S, Redelmeier T, Gonda I, Chan HK. Development and characterization of an in vitro release assay for liposomal ciprofloxacin for inhalation. J Pharm Sci. 2014;103(1):314\u201327.","journal-title":"J Pharm Sci"},{"issue":"3","key":"2464_CR29","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0005-2736(85)90008-2","volume":"818","author":"G Storm","year":"1985","unstructured":"Storm G, van Bloois L, Brouwer M, Crommelin DJA. The interaction of cytostatic drugs with adsorbents in aqueous media. The potential implications for liposome preparation. Biochim Biophys Acta Biomembr. 1985;818(3):343\u201351.","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"2464_CR30","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.2147\/IJN.S63190","volume":"9","author":"PP Jain","year":"2014","unstructured":"Jain PP, Leber R, Nagaraj C, et al. Liposomal nanoparticles encapsulating iloprost exhibit enhanced vasodilation in pulmonary arteries. Int J Nanomedicine. 2014;9:3249.","journal-title":"Int J Nanomedicine"},{"issue":"2","key":"2464_CR31","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/nprot.2007.521","volume":"3","author":"I Wiegand","year":"2008","unstructured":"Wiegand I, Hilpert K, Hancock REW. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc. 2008;3(2):163\u201375.","journal-title":"Nat Protoc"},{"issue":"5","key":"2464_CR32","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1002\/jps.23508","volume":"102","author":"SJ Wallace","year":"2013","unstructured":"Wallace SJ, Nation RL, Li J, Boyd BJ. Physicochemical aspects of the coformulation of colistin and azithromycin using liposomes for combination antibiotic therapies. J Pharm Sci. 2013;102(5):1578\u201387.","journal-title":"J Pharm Sci"},{"issue":"6","key":"2464_CR33","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/jps.23969","volume":"103","author":"D Cipolla","year":"2014","unstructured":"Cipolla D, Wu H, Gonda I, Eastman S, Redelmeier T, Chan HK. Modifying the release properties of liposomes toward personalized medicine. J Pharm Sci. 2014;103(6):1851\u201362.","journal-title":"J Pharm Sci"},{"issue":"1\u20132","key":"2464_CR34","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ijpharm.2013.11.011","volume":"459","author":"A Alinaghi","year":"2014","unstructured":"Alinaghi A, Rouini MR, Johari Daha F, Moghimi HR. The influence of lipid composition and surface charge on biodistribution of intact liposomes releasing from hydrogel-embedded vesicles. Int J Pharm. 2014;459(1\u20132):30\u20139.","journal-title":"Int J Pharm"},{"issue":"9","key":"2464_CR35","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1002\/jps.23203","volume":"101","author":"SJ Wallace","year":"2012","unstructured":"Wallace SJ, Li J, Nation RL, Prankerd RJ, Boyd BJ. Interaction of colistin and colistin methanesulfonate with liposomes: colloidal aspects and implications for formulation. J Pharm Sci. 2012;101(9):3347\u201359.","journal-title":"J Pharm Sci"},{"issue":"1","key":"2464_CR36","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0378-5173(97)00301-3","volume":"160","author":"C Mestres","year":"1998","unstructured":"Mestres C, Alsina MA, Busquets MA, Mur\u00e1nyi I, Reig F. Interaction of colistin with lipids in liposomes and monolayers. Int J Pharm. 1998;160(1):99\u2013107.","journal-title":"Int J Pharm"},{"issue":"11","key":"2464_CR37","doi-asserted-by":"publisher","first-page":"6601","DOI":"10.1073\/pnas.77.11.6601","volume":"77","author":"EL Bearer","year":"1980","unstructured":"Bearer EL, Friend DS. Anionic lipid domains: correlation with functional topography in a mammalian cell membrane. Proc Natl Acad Sci. 1980;77(11):6601\u20135.","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"2464_CR38","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1021\/bc500094d","volume":"25","author":"ZZ Deris","year":"2014","unstructured":"Deris ZZ, Swarbrick JD, Roberts KD, Azad MA, Akter J, Horne AS, et al. Probing the penetration of antimicrobial polymyxin lipopeptides into gram-negative bacteria. Bioconjug Chem. 2014;25(4):750\u201360.","journal-title":"Bioconjug Chem"},{"issue":"11","key":"2464_CR39","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1007\/s11095-016-2002-5","volume":"33","author":"D Cipolla","year":"2016","unstructured":"Cipolla D, Wu H, Eastman S, Redelmeier T, Gonda I, Chan HK. Tuning ciprofloxacin release profiles from Liposomally encapsulated Nanocrystalline drug. Pharm Res. 2016;33(11):2748\u201362.","journal-title":"Pharm Res"},{"issue":"9","key":"2464_CR40","doi-asserted-by":"publisher","first-page":"4856","DOI":"10.1128\/AAC.05996-11","volume":"56","author":"C Vidaillac","year":"2012","unstructured":"Vidaillac C, Benichou L, Duval RE. In vitro synergy of colistin combinations against colistin-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae isolates. Antimicrob Agents Chemother. 2012;56(9):4856\u201361.","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"2464_CR41","doi-asserted-by":"publisher","first-page":"5134","DOI":"10.1128\/AAC.05028-11","volume":"55","author":"PJ Bergen","year":"2011","unstructured":"Bergen PJ, Forrest A, Bulitta JB, et al. Clinically relevant plasma concentrations of colistin in combination with imipenem enhance pharmacodynamic activity against multidrug-resistant Pseudomonas aeruginosa at multiple inocula. Antimicrob Agents Chemother. 2011;55(11):5134\u201342.","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"2464_CR42","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S1473-3099(06)70580-1","volume":"6","author":"J Li","year":"2006","unstructured":"Li J, Nation RL, Turnidge JD, et al. Colistin: the re-emerging antibiotic for multidrug-resistant gram-negative bacterial infections. Lancet Infect Dis. 2006;6(9):589\u2013601.","journal-title":"Lancet Infect Dis"},{"key":"2464_CR43","first-page":"S469","volume":"16","author":"J Li","year":"2010","unstructured":"Li J, Poudyal A, Yu H, et al. Targeting multidrug-resistantpseudomonas aeruginosa: pharmacodynamics of the combination of colistin and ciprofloxacin. Clinical Microbiology & Infection. 2010;16:S469.","journal-title":"Clinical Microbiology & Infection"},{"issue":"3","key":"2464_CR44","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1023\/A:1022664406840","volume":"20","author":"TR Desai","year":"2003","unstructured":"Desai TR, Tyrrell GJ, Ng T, et al. In vitro evaluation of nebulization properties, antimicrobial activity, and regional airway surface liquid concentration of liposomal polymyxin B sulfate. Pharm Res. 2003;20(3):442\u20137.","journal-title":"Pharm Res"},{"issue":"6","key":"2464_CR45","doi-asserted-by":"publisher","first-page":"711","DOI":"10.2217\/fmb.13.39","volume":"8","author":"T Velkov","year":"2013","unstructured":"Velkov T, Roberts KD, Nation RL, et al. Pharmacology of polymyxins: new insights into an \u2018old\u2019class of antibiotics. Future Microbiol. 2013;8(6):711\u201324.","journal-title":"Future Microbiol"},{"issue":"3","key":"2464_CR46","doi-asserted-by":"publisher","first-page":"e02025","DOI":"10.1128\/AAC.02025-16","volume":"61","author":"YW Lin","year":"2017","unstructured":"Lin YW, Zhou QT, Cheah SE, et al. Pharmacokinetics\/pharmacodynamics of pulmonary delivery of colistin against Pseudomonas aeruginosa in a mouse lung infection model. Antimicrob Agents Chemother. 2017;61(3):e02025\u201316.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-018-2464-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-018-2464-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-018-2464-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T19:10:41Z","timestamp":1565291441000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-018-2464-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,9]]},"references-count":46,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["2464"],"URL":"https:\/\/doi.org\/10.1007\/s11095-018-2464-8","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,9]]},"assertion":[{"value":"21 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"187"}}